Abstract |
Based on the oxidation hypothesis high doses of alpha-tocopherol have been advocated to prevent atherosclerosis, but clinical trials failed to demonstrate a benefit. As specific oxylipids activate PPARgamma and LXRalpha, master regulators of lipid metabolism and cholesterol exporters, we hypothesized, that high dose alpha-tocopherol might interfere with reverse cholesterol transport out of the vessel wall. Human THP-1 cells, a foam cell model, were preincubated with alpha-tocopherol or carrier before exposure to oxidized LDL, delipidated HDL or control buffer. Specific mRNAs were quantified by real-time RT-PCR, LXRalpha activation by a reporter gene assay and cellular cholesterol homeostasis by oxLDL and dHDL facilitated uptake and efflux assays. alpha-Tocopherol significantly reduced baseline expression and stimulation by oxLDL of LXRalpha activity, CD36, ABCA1, and ABCG1. alpha-Tocopherol also reversed the suppression of CD36 and ABCA1 by dHDL. Thus alpha-Tocopherol compromises cellular lipid scavenging and channelling of cholesterol into reverse transport out of the vessel wall.
|
Authors | Sabine Rode, Tina Rubic, Reinhard L Lorenz |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 369
Issue 3
Pg. 868-72
(May 09 2008)
ISSN: 1090-2104 [Electronic] United States |
PMID | 18328805
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ABCA1 protein, human
- ABCG1 protein, human
- ATP Binding Cassette Transporter 1
- ATP Binding Cassette Transporter, Subfamily G, Member 1
- ATP-Binding Cassette Transporters
- Antioxidants
- CD36 Antigens
- Cholesterol, HDL
- DNA-Binding Proteins
- Lipoproteins, LDL
- Liver X Receptors
- NR1H3 protein, human
- Orphan Nuclear Receptors
- Receptors, Cytoplasmic and Nuclear
- oxidized low density lipoprotein
- Cholesterol
- alpha-Tocopherol
|
Topics |
- ATP Binding Cassette Transporter 1
- ATP Binding Cassette Transporter, Subfamily G, Member 1
- ATP-Binding Cassette Transporters
(antagonists & inhibitors)
- Antioxidants
(pharmacology)
- Atherosclerosis
(etiology, prevention & control)
- CD36 Antigens
(metabolism)
- Cholesterol
(metabolism)
- Cholesterol, HDL
(pharmacology)
- DNA-Binding Proteins
(agonists, antagonists & inhibitors, metabolism)
- Foam Cells
(drug effects, metabolism)
- Genes, Reporter
(drug effects)
- Humans
- Lipoproteins, LDL
(pharmacology)
- Liver X Receptors
- Orphan Nuclear Receptors
- Receptors, Cytoplasmic and Nuclear
(agonists, antagonists & inhibitors, metabolism)
- Transcription, Genetic
(drug effects)
- alpha-Tocopherol
(pharmacology)
|